As of June 8, 2026, the past week of analyst activity highlights significant movement in the Consumer Staples and Information Technology sectors. Notably, DG faced five downward revisions from firms including Barclays and Citigroup, while NVDA saw a substantial upward adjustment.
Upgrades and downgrades
Recent activity shows a split between broad industrial optimism and concentrated pressure on retail. NVDA NVDA saw an upgrade to $319 from China Renaissance. Other upgrades included DIS ($121→$126), HON ($268→$275), TSLA ($145→$475), ROKU ($150→$170), UNH ($395→$453), DE ($560→$590), and RTX ($210→$220).
Conversely, DG experienced a series of price target reductions, with Telsey Advisory Group lowering its outlook from $140 to $125. Healthcare also saw downward pressure, as HSBC reduced targets for both DHR ($270→$230) and TMO ($670→$540). SHW was also lowered by BMO Capital to $355 from $420.
| Ticker | Firm | Dir | Prior→Current |
|---|---|---|---|
| NVDA | China Ren. | Up | 0→319 |
| TSLA | JP Morgan | Up | 145→475 |
| DG | Citi | Down | 138→116 |
| TMO | HSBC | Down | 670→540 |
Limits of the data
These market revisions reflect individual firm views, which often diverge from the broader consensus mean target. Analysts may initiate coverage or adjust models based on proprietary internal metrics that differ significantly from the aggregate figures tracked by peers.